National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
RK-0202

 A substance that is being studied in the prevention of oral mucositis in patients receiving radiation therapy or chemotherapy for head and neck cancer.

Previous Definitions:risk ratio, ritonavir, ritual, Rituxan, rituximab
Next Definitions:RMP-7, RNA, Ro 31-7453, Ro 50-3821, rofecoxib